Nektar Therapeutics (NKTR)
67.10
-1.26
(-1.84%)
USD |
NASDAQ |
Sep 18, 16:00
68.50
+1.40
(+2.09%)
Pre-Market: 08:36
Nektar Therapeutics Total Long Term Debt (Quarterly) : 113.23M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 113.23M |
| March 31, 2026 | 120.90M |
| December 31, 2025 | 128.41M |
| September 30, 2025 | 144.90M |
| June 30, 2025 | 154.72M |
| March 31, 2025 | 164.82M |
| December 31, 2024 | 174.47M |
| September 30, 2024 | 184.59M |
| June 30, 2024 | 198.27M |
| March 31, 2024 | 212.57M |
| December 31, 2023 | 211.14M |
| September 30, 2023 | 225.80M |
| June 30, 2023 | 241.48M |
| March 31, 2023 | 254.52M |
| December 31, 2022 | 239.30M |
| September 30, 2022 | 281.74M |
| June 30, 2022 | 296.19M |
| March 31, 2022 | 308.24M |
| December 31, 2021 | 273.85M |
| September 30, 2021 | 310.48M |
| June 30, 2021 | 319.73M |
| March 31, 2021 | 329.70M |
| December 31, 2020 | 306.45M |
| September 30, 2020 | 205.40M |
| June 30, 2020 | 209.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 465.63M |
| December 31, 2019 | 438.40M |
| September 30, 2019 | 466.81M |
| June 30, 2019 | 420.46M |
| March 31, 2019 | 423.25M |
| December 31, 2018 | 308.66M |
| September 30, 2018 | 331.92M |
| June 30, 2018 | 334.94M |
| March 31, 2018 | 338.49M |
| December 31, 2017 | 320.99M |
| September 30, 2017 | 346.16M |
| June 30, 2017 | 350.00M |
| March 31, 2017 | 352.35M |
| December 31, 2016 | 334.83M |
| September 30, 2016 | 356.41M |
| June 30, 2016 | 360.53M |
| March 31, 2016 | 364.87M |
| December 31, 2015 | 346.36M |
| September 30, 2015 | 253.36M |
| June 30, 2015 | 255.50M |
| March 31, 2015 | 256.36M |
| December 31, 2014 | 233.23M |
| September 30, 2014 | 250.83M |
| June 30, 2014 | 252.46M |
| March 31, 2014 | 253.18M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Elite Pharmaceuticals, Inc. | 5.019M |
| Daré Bioscience, Inc. | 6.169M |
| Aclaris Therapeutics, Inc. | 1.262M |
| Eton Pharmaceuticals, Inc. | 28.99M |
| Journey Medical Corp. | 25.47M |